tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Advertisement

Newron Pharmaceuticals SpA (NWRN) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
CHF10.48
CHF209.19M
8.75
35.23%
0 Buy
0 Hold
0 Sell
Hold
Molecular Partners AG
CHF2.80
CHF112.85M
-36.48%
1 Buy
1 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF45.20
CHF550.56M
7.56
-2.80%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.64
CHF839.50M
127.81%
1 Buy
2 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF10.86
$140.78M
2.58
22.85%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF20.00
CHF115.35M
3.71
-40.12%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:NWRN
Newron Pharmaceuticals SpA
10.48
2.88
37.89%
CH:MOLN
Molecular Partners AG
2.80
-1.58
-36.04%
CH:BSLN
Basilea Pharmaceutica
45.20
-1.15
-2.48%
CH:IDIA
Idorsia Ltd
3.64
2.15
144.30%
CH:SANN
Santhera Pharmaceuticals Holding
10.86
2.01
22.71%
CH:XLS
Xlife Sciences Ltd.
20.00
-10.80
-35.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis